iRhythm Technologies (NSDQ:IRTC) posted second-quarter results this week that beat the consensus on Wall Street. The San Francisco-based company reported losses of $20.4 million, or -75¢ per share, on sales of $50.9 million for the three months ended June 30, for a sales loss of -3% compared with Q2 2019. Earnings per share were -75¢, 7¢ […]
iRhythm Technologies names new chief financial officer
iRhythm Technologies (NSDQ:IRTC) this week said it appointed Douglas Devine as chief financial officer, effective June 22. Devine succeeds Matthew Garrett who announced his intention to step down. Garrett will assist in the transition of CFO responsibilities and will remain at the company under an advisory role for up to a year. “On behalf of everyone […]
iRhythm Technologies up on Street-beating Q1 results
iRhythm Technologies (NSDQ:IRTC) posted first-quarter results that beat the consensus on Wall Street. The company reported losses of -$9.1 million, or -34¢ per share, on sales of $63.5 million for the three months ended March 31, for a sales growth of 31.5% compared with Q1 2019. Earnings per share were -34¢, 28¢ ahead of The Street, […]
iRhythm Technologies beats on revenue, misses on earnings in Q4 results
iRhythm Technologies (NSDQ:IRTC) posted fourth-quarter results today that beat the revenue consensus on Wall Street but missed on earnings. The San Francisco-based company reported losses of $17.3 million, or -65¢ per share, on sales of $59.1 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 41.5% compared with Q4 2018. […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully […]
iRhythm releases delayed Q3 earnings report, falls short of Street projections
iRhythm Technologies (NSDQ:IRTC) shares are slightly up today on third-quarter results that came up short of the consensus forecast. The San Francisco-based company delayed its third-quarter report in November due to a previously disclosed material weaknesses. At the time, the company said it identified errors that affected prior periods while preparing the quarterly report for the […]
iRhythm touts AFib study
iRhythm Technologies (NSDQ:IRTC) announced that it is participating in a new Bristol-Myers Squibb–Pfizer (NYSE:PFE) Alliance study for reducing stroke by screening for undiagnosed atrial fibrillation in elderly individuals. The goal of the “Guard-AF” study is to determine if earlier detection of AFib can impact the rate of stroke through screening previously undiagnosed people who are at least […]
iRhythm Technologies won’t file 10-Q, citing material weaknesses
iRhythm Technologies (NSDQ:IRTC) this week said it would not be filing its quarterly report on Form 10-Q, citing previously disclosed material weaknesses, according to an SEC filing. The San Francisco-based company said it identified errors that affected prior periods while preparing the quarterly report for the period ended Sept. 30, 2019. The errors could affect the […]
iRhythm closes $115m offering
iRhythm Technologies (NSDQ:IRTC) said yesterday that it closed its underwritten public offering of common stock for gross proceeds exceeding $100 million. The San Fransisco-based company said it offered nearly 1.6 million shares at $73 per share, including the exercise in full of the underwriters’ option to purchase an additional 205,479 shares. iRhythm initially estimated net proceeds […]
iRhythm prices $100m offering
iRhythm Technologies (NSDQ:IRTC) yesterday priced a stock offering worth at least $100 million it plans to use in part to fund a co-development deal with Alphabet (NSDQ:GOOGL) life sciences unit Verily. The 1.37-million-share flotation includes a 30-day underwriters option on another 205,000 shares that would add $15 million if exercised in full. The offering is slated to close […]
iRhythm unveils $13m Verily afib deal, readies $100m offering
iRhythm Technologies (NSDQ:IRTC) said yesterday that it inked a deal worth nearly $13 million with Alphabet (NSDQ:GOOGL) life sciences unit Verily to develop AI-based screening, diagnosis and management technology for atrial fibrillation and said it’s readying a stock offering worth $100 million in part to back the collaboration. The deal to integrate Verily’s data analytics into […]
